{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:40:52Z","timestamp":1760834452686,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009038","name":"University of Guilan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005421","name":"Guilan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jocn.2021.08.012","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T17:21:12Z","timestamp":1630171272000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Overexpression of Hepatocyte growth factor and its soluble receptor (s-cMet) in the serum of patients with different grades of meningioma"],"prefix":"10.1016","volume":"93","author":[{"given":"Farhad","family":"Mashayekhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheila Talesh","family":"Sasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zivar","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2021.08.012_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2012.00019","article-title":"Family history of cancer in benign brain tumor subtypes versus gliomas","volume":"2","author":"Ostrom","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2021.08.012_b0010","doi-asserted-by":"crossref","first-page":"101562","DOI":"10.1016\/j.canep.2019.07.001","article-title":"Incidence, mortality and outcome of meningiomas: a population-based study from Germany","volume":"62","author":"Holleczek","year":"2019","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"10.1016\/j.jocn.2021.08.012_b0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.jocn.2021.08.012_b0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijrobp.2011.08.010","article-title":"Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas\u2013clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy","volume":"83","author":"Adeberg","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.jocn.2021.08.012_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jocn.2012.02.007","article-title":"Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas","volume":"20","author":"Yew","year":"2013","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.jocn.2021.08.012_b0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4132\/jptm.2014.10.13","article-title":"Expression of c-MET in invasive meningioma","volume":"49","author":"Yun","year":"2015","journal-title":"J Pathol Transl Med"},{"issue":"1","key":"10.1016\/j.jocn.2021.08.012_b0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2004.04.026","article-title":"Coexpression of hepatocyte growth factor\/scatter factor (HGF\/SF) and its receptor cMET predict recurrence of meningiomas","volume":"213","author":"Mart\u00ednez-Rumayor","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jocn.2021.08.012_b0040","doi-asserted-by":"crossref","unstructured":"Nakamura T, Sakai K, Nakamura T, Matsumoto K. Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol. 2011:188\u2013202.","DOI":"10.1111\/j.1440-1746.2010.06549.x"},{"key":"10.1016\/j.jocn.2021.08.012_b0045","first-page":"82","article-title":"Biology of MET: a double life between normal tissue repair and tumor progression","volume":"3","author":"Petrini","year":"2015","journal-title":"Ann Transl Med"},{"issue":"3","key":"10.1016\/j.jocn.2021.08.012_b0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1568009616666161215162515","article-title":"The role of EGFR-met interactions in the pathogenesis of glioblastoma and resistance to treatment","volume":"17","author":"Guo","year":"2017","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.jocn.2021.08.012_b0055","first-page":"5911","article-title":"Hepatocyte growth factor\/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma","volume":"61","author":"Dong","year":"2001","journal-title":"Cancer Res"},{"issue":"1-2","key":"10.1016\/j.jocn.2021.08.012_b0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0006-8993(02)03975-6","article-title":"Cytokines regulate c-Met expression in cultured astrocytes","volume":"962","author":"Shimazaki","year":"2003","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.jocn.2021.08.012_b0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jb\/mvv027","article-title":"Hepatocyte growth factor and Met in drug discovery","volume":"157","author":"Sakai","year":"2015","journal-title":"J Biochem"},{"issue":"20","key":"10.1016\/j.jocn.2021.08.012_b0070","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.3390\/ijms21207546","article-title":"HGF\/MET signaling in malignant brain tumors","volume":"21","author":"Mulcahy","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.jocn.2021.08.012_b0075","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1091\/mbc.e08-09-0969","article-title":"Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis","volume":"20","author":"Foveau","year":"2009","journal-title":"Mol Biol Cell"},{"issue":"3","key":"10.1016\/j.jocn.2021.08.012_b0080","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/cas.13156","article-title":"Hepatocyte growth factor\/MET in cancer progression and biomarker discovery","volume":"108","author":"Matsumoto","year":"2017","journal-title":"Cancer Sci"},{"issue":"12","key":"10.1016\/j.jocn.2021.08.012_b0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/cancers9050044","article-title":"HGF\/Met signaling in cancer invasion: the impact on cytoskeleton remodeling","volume":"9","author":"Xiang","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jocn.2021.08.012_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clineuro.2018.02.041","article-title":"Crizotinib and erlotinib inhibits growth of c-Met+\/EGFRvIII+ primary human glioblastoma xenografts","volume":"171","author":"Goodwin","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"10.1016\/j.jocn.2021.08.012_b0095","doi-asserted-by":"crossref","first-page":"E1390","DOI":"10.1210\/jc.2012-1150","article-title":"Self-control of HGF regulation on human trophoblast cell invasion via enhancing c-Met receptor shedding by ADAM10 and ADAM17","volume":"97","author":"Yang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jocn.2021.08.012_b0100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ar.20757","article-title":"Molecular and cellular mechanisms of ectodomain shedding","volume":"293","author":"Hayashida","year":"2010","journal-title":"Anat Rec (Hoboken)"},{"issue":"2","key":"10.1016\/j.jocn.2021.08.012_b0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00595-014-0886-4","article-title":"The soluble VEGFR1 concentration in the serum of patients with colorectal cancer","volume":"45","author":"Abbasi","year":"2015","journal-title":"Surg Today"},{"key":"10.1016\/j.jocn.2021.08.012_b0110","first-page":"168","article-title":"Soluble cMet expression in the serum of patients with different stages of prostate cancer","volume":"20","author":"Mashayekhi","year":"2015","journal-title":"Eur J Oncol Environ Health"},{"issue":"5","key":"10.1016\/j.jocn.2021.08.012_b0115","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00404-013-3082-7","article-title":"Soluble c-Met expression in the peritoneal fluid and serum of patients with different stages of endometriosis","volume":"289","author":"KhoshdelRad","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"10.1016\/j.jocn.2021.08.012_b0120","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamaophthalmol.2015.1766","article-title":"Potential role of Soluble c-Met as a new candidate biomarker of metastatic uveal melanoma","volume":"133","author":"Barisione","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.jocn.2021.08.012_b0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12987-015-0020-z","article-title":"Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis","volume":"12","author":"Ramezani","year":"2015","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"10.1016\/j.jocn.2021.08.012_b0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/neuonc\/noq198","article-title":"A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma","volume":"13","author":"Wen","year":"2011","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.jocn.2021.08.012_b0135","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/cncr.10594","article-title":"Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma","volume":"94","author":"Arrieta","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2021.08.012_b0140","first-page":"531","article-title":"Expression of hepatocyte growth factor\/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review)","volume":"3","author":"Moriyama","year":"1999","journal-title":"Int J Mol Med"},{"issue":"2","key":"10.1016\/j.jocn.2021.08.012_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3835(98)00014-7","article-title":"Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer","volume":"126","author":"Maemura","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jocn.2021.08.012_b0150","first-page":"1263","article-title":"Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue","volume":"20","author":"Beppu","year":"2000","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.jocn.2021.08.012_b0155","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1038\/bjc.2014.230","article-title":"Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer","volume":"110","author":"Takahashi","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jocn.2021.08.012_b0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/5584_2016_66","article-title":"Clinical implications of hepatocyte growth factor, interleukin-20, and interleukin-22 in serum and bronchoalveolar fluid of patients with non-small cell lung cancer","volume":"952","author":"Naumnik","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"30","key":"10.1016\/j.jocn.2021.08.012_b0165","doi-asserted-by":"crossref","first-page":"31149","DOI":"10.1074\/jbc.M403587200","article-title":"Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain","volume":"279","author":"Heiz","year":"2004","journal-title":"J Biol Chem"},{"issue":"1-2","key":"10.1016\/j.jocn.2021.08.012_b0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3835(98)00127-X","article-title":"Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors","volume":"132","author":"K\u00f6ko\u011flu","year":"1998","journal-title":"Cancer Lett"},{"issue":"1-2","key":"10.1016\/j.jocn.2021.08.012_b0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-5728(01)00425-8","article-title":"Evidence of recurrent atypical meningioma with rhabdoid transformation and expression of pyrogenic cytokines in a child presenting with a marked acute-phase response: case report and review of the literature","volume":"120","author":"Rittierodt","year":"2001","journal-title":"J Neuroimmunol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821004318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821004318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:25:48Z","timestamp":1760822748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821004318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":35,"alternative-id":["S0967586821004318"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.08.012","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of Hepatocyte growth factor and its soluble receptor (s-cMet) in the serum of patients with different grades of meningioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}